Clinical Trial

Phase II Clinical Trial of Chidamide Combined With AK112 for Second-line and Advanced Bone and Soft Tissue Sarcoma

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated October 15, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
Evaluation of the efficacy and safety of Xidabenzamide combined with AK112 for advanced bone and soft tissue sarcoma of second-line and above.
Trial Details
NCT Number NCT06637007
Lead Sponsor Shanxi Province Cancer Hospital
Conditions Sarcoma,Soft Tissue, Sarcoma, Sarcoma of Bone
Enrollment 30 participants
Start Date 2024-08-01
Primary Completion 2024-12-31 (estimated)
Study Completion 2024-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-10-15